Tissue Penetration and Pharmacokinetics of Tigecycline in Diabetic Patients with Chronic Wound Infections Described by Using In Vivo Microdialysis
- 1 December 2010
- journal article
- clinical trial
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (12) , 5209-5213
Abstract
Tissue penetration of systemic antibiotics is an important consideration for positive outcomes in diabetic patients. Herein we describe the exposure profile and penetration of tigecycline in the interstitial fluid of wound margins versus that of uninfected thigh tissue in 8 adult diabetic patients intravenously (IV) administered 100 mg and then 50 mg of tigecycline twice daily for 3 to 5 doses. Prior to administration of the first dose, 2 microdialysis catheters were inserted into the subcutaneous tissue, the first within 10 cm of the wound margin and the second in the thigh of the same extremity. Samples for determination of plasma and tissue concentrations were simultaneously collected over 12 h under steady-state conditions. Tissue concentrations were corrected for percent in vivo recovery by the retrodialysis technique. Plasma samples were also collected for determination of protein binding at 1, 6, and 12 h postdose for each patient. Protein binding data were corrected using a fitted polynomial equation. The mean patient weight was 95.1 kg (range, 63.6 to 149.2 kg), the mean patient age was 63.5 ± 9.4 years, and 75% of the patients were males. The mean values for the plasma, thigh, and wound free area under the concentration-time curve from 0 to 24 h (fAUC 0-24 ) were 2.65 ± 0.33, 2.52 ± 1.15, and 2.60 ± 1.02 μg·h/ml, respectively. Protein binding was nonlinear, with the percentage of free drug increasing with decreasing serum concentrations. Exposure values for thigh tissue and wound tissue were similar ( P = 0.986). Mean steady-state tissue concentrations for the thigh and wound were similar at 0.12 ± 0.02 μg/ml, and clearance from the tissues appeared similar to that from plasma. Tissue penetration ratios (tissue f AUC/plasma f AUC) were 99% in the thigh and 100% in the wound ( P = 0.964). Tigecycline penetrated equally well into wound and uninfected tissue of the same extremity.Keywords
This publication has 20 references indexed in Scilit:
- Pharmacodynamics of Tigecycline against Phenotypically Diverse Staphylococcus aureus Isolates in a Murine Thigh ModelAntimicrobial Agents and Chemotherapy, 2009
- Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: Results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007Clinical Therapeutics, 2008
- Clinical Microdialysis in Skin and Soft Tissues: An UpdateThe Journal of Clinical Pharmacology, 2008
- Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Skin and Skin-Structure InfectionsAntimicrobial Agents and Chemotherapy, 2007
- Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg doseJournal of Antimicrobial Chemotherapy, 2006
- Pharmacokinetic Profile of Tigecycline in Serum and Skin Blister Fluid of Healthy Subjects after Multiple Intravenous AdministrationsAntimicrobial Agents and Chemotherapy, 2005
- Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy SubjectsAntimicrobial Agents and Chemotherapy, 2005
- Quantitation of tigecycline, a novel glycyclcycline, by liquid chromatographyJournal of Chromatography B, 2004
- Medical Treatment of Diabetic Foot InfectionsClinical Infectious Diseases, 2004
- Diagnosing and treating diabetic foot infectionsDiabetes/Metabolism Research and Reviews, 2004